Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.
dc.contributor.author | Atahan, L. | |
dc.contributor.author | Yildiz, F. | |
dc.contributor.author | Cengiz, M. | |
dc.contributor.author | Kaplan, B. | |
dc.contributor.author | Ozkan, M. | |
dc.contributor.author | Haydaroglu, A. | |
dc.contributor.author | Sengoz, M. | |
dc.contributor.author | Korcums, A. F. | |
dc.contributor.author | Akmansu, M. | |
dc.contributor.author | Engin, K. | |
dc.date.accessioned | 2019-10-27T19:20:42Z | |
dc.date.available | 2019-10-27T19:20:42Z | |
dc.date.issued | 2006 | |
dc.department | Ege Üniversitesi | en_US |
dc.description | 48th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology -- NOV 05-09, 2006 -- Philadelphia, PA | en_US |
dc.description.sponsorship | Amer Soc Therapeut Radiol & Oncol | en_US |
dc.identifier.doi | 10.1016/j.ijrobp.2006.07.980 | |
dc.identifier.endpage | S525 | en_US |
dc.identifier.issn | 0360-3016 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | S524 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.ijrobp.2006.07.980 | |
dc.identifier.uri | https://hdl.handle.net/11454/38904 | |
dc.identifier.volume | 66 | en_US |
dc.identifier.wos | WOS:000241221602079 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.ispartof | International Journal of Radiation Oncology Biology Physics | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study. | en_US |
dc.type | Conference Object | en_US |